| Large cell carcinoma of the lung: LDCT features and survival in screen-detected cases M Mascalchi, D Puliti, E Cavigli, FO Cortés-Ibáñez, G Picozzi, L Carrozzi, ... European journal of radiology 179, 111679, 2024 | | 2024 |
| Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study M Benevolo, G Ronco, P Mancuso, F Carozzi, L De Marco, E Allia, ... Ebiomedicine 104, 2024 | 1 | 2024 |
| About a “reasonable proposal” on overdiagnosis in breast cancer screening E Paci, D Puliti | | 2024 |
| Comparing accuracy of tomosynthesis plus digital mammography or synthetic 2D mammography in breast cancer screening: baseline results of the MAITA RCT consortium PG Rossi, P Mancuso, P Pattacini, C Campari, A Nitrosi, V Iotti, A Ponti, ... European Journal of Cancer 199, 113553, 2024 | 3 | 2024 |
| Baseline Cell-Free DNA Can Predict Malignancy of Nodules Observed in the ITALUNG Screening Trial S Bisanzi, D Puliti, G Picozzi, C Romei, F Pistelli, A Deliperi, G Carreras, ... Cancers 16 (12), 2276, 2024 | | 2024 |
| Accuracy and Reproducibility of Cytology Triage in a HPV-Based Primary Screening Setting: A Revision of 384 Pap Tests S Cannistrà, F Carozzi, C Di Stefano, M Matucci, G Pompeo, G Gorini, ... Acta Cytologica 67 (6), 618-628, 2023 | | 2023 |
| Relationship between baseline prostate-specific antigen on cancer detection and prostate cancer death: long-term follow-up from the European randomized study of screening for … S Remmers, CH Bangma, RA Godtman, SV Carlsson, A Auvinen, ... European urology 84 (5), 503-509, 2023 | 17 | 2023 |
| Lung cancer screening with low-dose CT: what we have learned in two decades of ITALUNG and what is yet to be addressed M Mascalchi, G Picozzi, D Puliti, S Diciotti, A Deliperi, C Romei, F Falaschi, ... Diagnostics 13 (13), 2197, 2023 | 8 | 2023 |
| Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trial M Mascalchi, C Romei, C Marzi, S Diciotti, G Picozzi, F Pistelli, M Zappa, ... European Radiology 33 (5), 3115-3123, 2023 | 7 | 2023 |
| Two Decades of ITALUNG. What We Have Learned and What Is Yet to Be Addressed in Lung Cancer Screening with Low Dose CT M Mascalchi, G Picozzi, D Puliti, S Diciotti, A Deliperi, C Romei, F Falaschi, ... Preprints, 2023 | | 2023 |
| Performance of HPV E6/E7 mRNA assay as primary screening test: results from the NTCC2 trial P Giorgi Rossi, G Ronco, P Mancuso, F Carozzi, E Allia, S Bisanzi, ... International Journal of Cancer 151 (7), 1047-1058, 2022 | 10 | 2022 |
| Single CT Appointment for Double Lung and Colorectal Cancer Screening: Is the Time Ripe? M Mascalchi, G Picozzi, D Puliti, G Gorini, P Mantellini, L Sali Diagnostics 12 (10), 2326, 2022 | | 2022 |
| Gender effect in the ITALUNG screening trial. A comparison with UKLS and other trials D Puliti, G Picozzi, G Gorini, L Carrozzi, M Mascalchi The Lancet Regional Health–Europe 13, 2022 | 8 | 2022 |
| Moderate-severe coronary calcification predicts long-term cardiovascular death in CT lung cancer screening: The ITALUNG trial M Mascalchi, D Puliti, C Romei, G Picozzi, A De Liperi, S Diciotti, ... European Journal of Radiology 145, 110040, 2021 | 16 | 2021 |
| Intervention-related deaths in the European randomized study of screening for prostate cancer RA Godtman, S Remmers, G Aus, V Nelen, L van Eycken, A Villers, ... European Urology Open Science 34, 27-32, 2021 | 2 | 2021 |
| Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk P Giorgi Rossi, O Djuric, V Hélin, S Astley, P Mantellini, A Nitrosi, ... Scientific reports 11 (1), 19884, 2021 | 9 | 2021 |
| PD13-04 PROSTATE CANCER SPECIFIC MORTALITY IN THE ERSPC TRIAL: WHAT IS THE ROLE OF SCREENING RESULT AND ADHERENCE C Wetterauer, S Remmers, LW Prause, J Hugosson, TLJ Tammela, ... Journal of Urology 206 (Supplement 3), e210-e211, 2021 | | 2021 |
| Determinants of p16/Ki‐67 adequacy and positivity in HPV‐positive women from a screening population M Benevolo, P Mancuso, E Allia, D Gustinucci, S Bulletti, E Cesarini, ... Cancer Cytopathology 129 (5), 383-393, 2021 | 6 | 2021 |
| Prognostic selection and long-term survival analysis to assess overdiagnosis risk in lung cancer screening randomized trials E Paci, D Puliti, FM Carozzi, L Carrozzi, F Falaschi, AL Pegna, ... Journal of medical screening 28 (1), 39-47, 2021 | 11 | 2021 |
| Smoking cessation in the ITALUNG lung cancer screening: what does “teachable moment” mean? F Pistelli, F Aquilini, F Falaschi, D Puliti, C Ocello, A Lopes Pegna, ... Nicotine and Tobacco Research 22 (9), 1484-1491, 2020 | 48 | 2020 |
